METHYLPREDNISOLONE

METHYLPREDNISOLONE was reported 140189 times

METHYLPREDNISOLONE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BLOOD PRESSURE DIASTOLIC ABNORMAL 1503 0.5903
1 BLOOD PRESSURE SYSTOLIC ABNORMAL 1390 0.5618
2 VAGINAL FLATULENCE 135 0.4455
3 NEUROLOGIC NEGLECT SYNDROME 185 0.3327
4 URINE LEUKOCYTE ESTERASE POSITIVE 214 0.3057
5 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 202 0.3024
6 MYCOBACTERIUM CHELONAE INFECTION 219 0.2963
7 LUPUS VULGARIS 359 0.2849
8 DELAYED GRAFT FUNCTION 198 0.2785
9 PULMONARY MUCORMYCOSIS 140 0.2652
10 URINARY SEDIMENT PRESENT 170 0.2640
11 CRYSTAL URINE PRESENT 144 0.2590
12 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 145 0.2585
13 FACET JOINT SYNDROME 825 0.2531
14 RED BLOOD CELLS URINE POSITIVE 241 0.2492
15 SECONDARY IMMUNODEFICIENCY 284 0.2337
16 RETINITIS 403 0.2331
17 SERONEGATIVE ARTHRITIS 263 0.2295
18 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 162 0.2253
19 CAROTID ARTERY THROMBOSIS 191 0.2250
20 PULMONARY NOCARDIOSIS 184 0.2233
21 RHEUMATIC FEVER 991 0.2221
22 STEROID DIABETES 331 0.2205
23 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 503 0.2145
24 DISLOCATION OF VERTEBRA 482 0.2111
25 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 422 0.1981
26 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 274 0.1939
27 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 400 0.1929
28 GRANULOMATOSIS WITH POLYANGIITIS 226 0.1872
29 PERIPHERAL VENOUS DISEASE 753 0.1842
30 WHITE BLOOD CELLS URINE POSITIVE 339 0.1800
31 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 1284 0.1790
32 CYTOMEGALOVIRUS VIRAEMIA 791 0.1776
33 STRONGYLOIDIASIS 284 0.1756
34 HUMAN HERPESVIRUS 6 INFECTION 332 0.1755
35 MUCORMYCOSIS 453 0.1742
36 POLYOMAVIRUS VIRAEMIA 184 0.1733
37 TEMPERATURE REGULATION DISORDER 374 0.1677
38 ONYCHOMADESIS 698 0.1662
39 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 457 0.1652
40 CYTOMEGALOVIRUS INFECTION REACTIVATION 729 0.1649
41 PHARYNGEAL PARAESTHESIA 261 0.1644
42 DIFFUSE ALVEOLAR DAMAGE 189 0.1643
43 ACINETOBACTER INFECTION 178 0.1626
44 ENTEROBACTER INFECTION 271 0.1611
45 TRANSPLANT REJECTION 1284 0.1601
46 PARVOVIRUS B19 INFECTION 141 0.1575
47 BK VIRUS INFECTION 530 0.1570
48 DUODENAL ULCER PERFORATION 1162 0.1561
49 DEEP VEIN THROMBOSIS POSTOPERATIVE 310 0.1548
50 PNEUMONIA CYTOMEGALOVIRAL 299 0.1538
51 CYTOMEGALOVIRUS TEST POSITIVE 273 0.1530
52 SWOLLEN JOINT COUNT INCREASED 483 0.1513
53 PSEUDOMONAL SEPSIS 264 0.1506
54 X-RAY ABNORMAL 267 0.1492
55 LYMPHOCYTE PERCENTAGE DECREASED 200 0.1488
56 NEUTROPHIL PERCENTAGE INCREASED 187 0.1482
57 GRAFT VERSUS HOST DISEASE IN SKIN 324 0.1469
58 COMPLICATIONS OF TRANSPLANTED KIDNEY 332 0.1463
59 CYTOMEGALOVIRUS INFECTION 2412 0.1450
60 ADJUSTMENT DISORDER 188 0.1446
61 ONYCHOMYCOSIS 624 0.1421
62 INFECTION REACTIVATION 161 0.1406
63 KIDNEY TRANSPLANT REJECTION 674 0.1403
64 ADENOVIRUS INFECTION 404 0.1392
65 BRONCHOPULMONARY ASPERGILLOSIS 1076 0.1386
66 ENTEROCOCCAL INFECTION 668 0.1381
67 STENOTROPHOMONAS INFECTION 187 0.1378
68 BLOOD PRESSURE DIASTOLIC DECREASED 1015 0.1374
69 ASPERGILLUS INFECTION 901 0.1371
70 PNEUMATOSIS INTESTINALIS 391 0.1370
71 PEMPHIGUS 1705 0.1362
72 NOCARDIOSIS 347 0.1355
73 PNEUMOMEDIASTINUM 243 0.1343
74 CYTOMEGALOVIRUS CHORIORETINITIS 262 0.1342
75 HYPERCHOLESTEROLAEMIA 1292 0.1337
76 EAR PRURITUS 469 0.1336
77 VIRAEMIA 185 0.1335
78 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 669 0.1313
79 SYSTEMIC MYCOSIS 152 0.1301
80 CUSHINGOID 411 0.1279
81 CYTOMEGALOVIRUS COLITIS 294 0.1277
82 PNEUMOCYSTIS JIROVECII INFECTION 148 0.1238
83 BREAST CANCER STAGE III 799 0.1232
84 BLOOD PRESSURE SYSTOLIC INCREASED 2405 0.1232
85 HELICOBACTER INFECTION 1262 0.1227
86 KLEBSIELLA INFECTION 617 0.1219
87 BLEPHAROSPASM 767 0.1217
88 LUPUS NEPHRITIS 226 0.1207
89 MUSCLE INJURY 1001 0.1207
90 SYSTEMIC CANDIDA 300 0.1194
91 EPSTEIN-BARR VIRAEMIA 132 0.1190
92 FOLLICULITIS 1244 0.1185
93 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 155 0.1177
94 VARICELLA ZOSTER VIRUS INFECTION 244 0.1176
95 BURSITIS 1402 0.1154
96 ENCEPHALITIS AUTOIMMUNE 151 0.1148
97 BLOOD PRESSURE DIASTOLIC INCREASED 527 0.1141
98 EPSTEIN-BARR VIRUS INFECTION 704 0.1126
99 RHEUMATOID FACTOR POSITIVE 650 0.1124
100 WOUND INFECTION 1198 0.1093
101 GASTROENTERITIS NOROVIRUS 145 0.1091
102 HAND DEFORMITY 1432 0.1091
103 BONE EROSION 381 0.1076
104 GRAFT VERSUS HOST DISEASE 772 0.1073
105 CRYPTOCOCCOSIS 174 0.1067
106 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 794 0.1057
107 LIVER TRANSPLANT REJECTION 190 0.1057
108 GRIP STRENGTH DECREASED 924 0.1049
109 SUSPECTED OFF LABEL USE 473 0.1046
110 PNEUMOCYSTIS JIROVECII PNEUMONIA 1041 0.1036
111 C-REACTIVE PROTEIN ABNORMAL 663 0.1033
112 PARAINFLUENZAE VIRUS INFECTION 157 0.1031
113 FINGER DEFORMITY 495 0.1021
114 INTERVERTEBRAL DISCITIS 192 0.1017
115 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 163 0.1017
116 BLOOD PRESSURE FLUCTUATION 2402 0.1000
117 PNEUMONIA KLEBSIELLA 183 0.0995
118 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 319 0.0965
119 JOINT RANGE OF MOTION DECREASED 1292 0.0962
120 ACUTE GRAFT VERSUS HOST DISEASE 439 0.0958
121 JC VIRUS INFECTION 152 0.0950
122 CULTURE URINE POSITIVE 133 0.0946
123 SYNOVITIS 1662 0.0921
124 CHRONIC GRAFT VERSUS HOST DISEASE 331 0.0916
125 PERICARDITIS 1534 0.0912
126 URINE KETONE BODY PRESENT 142 0.0899
127 INFUSION RELATED REACTION 5934 0.0894
128 FEMALE GENITAL TRACT FISTULA 151 0.0884
129 LIP DRY 798 0.0878
130 THROMBOTIC MICROANGIOPATHY 849 0.0870
131 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 153 0.0865
132 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 821 0.0859
133 NAIL DISORDER 743 0.0848
134 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 167 0.0845
135 URINE ABNORMALITY 380 0.0835
136 VENOOCCLUSIVE DISEASE 208 0.0830
137 BACTERIAL TEST POSITIVE 185 0.0829
138 INFUSION SITE REACTION 246 0.0823
139 CYSTITIS HAEMORRHAGIC 329 0.0815
140 RED BLOOD CELL SEDIMENTATION RATE INCREASED 878 0.0793
141 RADICULOPATHY 209 0.0792
142 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 208 0.0781
143 RED CELL DISTRIBUTION WIDTH INCREASED 324 0.0779
144 PSEUDOMONAS INFECTION 667 0.0777
145 BACTERIAL SEPSIS 245 0.0752
146 HYPOGAMMAGLOBULINAEMIA 492 0.0748
147 EMPYEMA 147 0.0739
148 PERSONALITY DISORDER 192 0.0732
149 URINE ANALYSIS ABNORMAL 216 0.0722
150 COELIAC DISEASE 707 0.0720
151 BLOOD IMMUNOGLOBULIN G DECREASED 175 0.0706
152 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 157 0.0702
153 MONOCYTE COUNT INCREASED 252 0.0693
154 STAPHYLOCOCCAL BACTERAEMIA 300 0.0689
155 HISTIOCYTOSIS HAEMATOPHAGIC 204 0.0686
156 FOOD ALLERGY 523 0.0677
157 C-REACTIVE PROTEIN INCREASED 2455 0.0674
158 STAPHYLOCOCCAL SEPSIS 332 0.0672
159 LIVE BIRTH 560 0.0669
160 ORAL PRURITUS 151 0.0657
161 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1861 0.0656
162 BACK INJURY 711 0.0653
163 PROCTITIS 182 0.0649
164 GLOSSODYNIA 1454 0.0649
165 TRANSPLANT FAILURE 159 0.0648
166 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 532 0.0644
167 BODY TEMPERATURE DECREASED 627 0.0636
168 ESCHERICHIA INFECTION 520 0.0632
169 OESOPHAGEAL CANDIDIASIS 251 0.0629
170 HYPERPARATHYROIDISM SECONDARY 157 0.0626
171 HERPES SIMPLEX 407 0.0626
172 PROTEIN URINE PRESENT 309 0.0619
173 LYMPHOCYTE COUNT DECREASED 1073 0.0606
174 IRRITABLE BOWEL SYNDROME 1295 0.0603
175 PRODUCT LABEL CONFUSION 348 0.0597
176 RHINOVIRUS INFECTION 232 0.0595
177 APLASTIC ANAEMIA 305 0.0583
178 MULTIPLE-DRUG RESISTANCE 180 0.0580
179 PNEUMONIA FUNGAL 228 0.0577
180 FIBROMYALGIA 1401 0.0576
181 WOUND 1607 0.0574
182 BRAIN ABSCESS 145 0.0572
183 CHRONIC SINUSITIS 215 0.0572
184 LIVER INJURY 1405 0.0572
185 OBESITY 899 0.0564
186 ESCHERICHIA SEPSIS 162 0.0558
187 MYOPATHY 482 0.0557
188 DERMATOMYOSITIS 141 0.0556
189 GLOMERULONEPHRITIS 135 0.0551
190 FOETAL DEATH 285 0.0549
191 SYSTEMIC LUPUS ERYTHEMATOSUS 1949 0.0549
192 COVID-19 PNEUMONIA 647 0.0547
193 PUSTULAR PSORIASIS 188 0.0547
194 RESPIRATORY RATE INCREASED 482 0.0542
195 URINARY TRACT INFECTION BACTERIAL 136 0.0538
196 NEPHROGENIC ANAEMIA 247 0.0533
197 TYPE 2 DIABETES MELLITUS 1778 0.0528
198 OXYGEN SATURATION DECREASED 2959 0.0526
199 DISSEMINATED TUBERCULOSIS 135 0.0526
200 WALKING AID USER 344 0.0521
201 ESCHERICHIA URINARY TRACT INFECTION 221 0.0519
202 HEART RATE DECREASED 1798 0.0512
203 DEMYELINATION 209 0.0510
204 CANDIDA INFECTION 861 0.0509
205 CLOSTRIDIUM DIFFICILE COLITIS 540 0.0509
206 PULMONARY ALVEOLAR HAEMORRHAGE 283 0.0504
207 IMMUNODEFICIENCY 749 0.0502
208 VASCULITIS 566 0.0485
209 ACUTE RESPIRATORY DISTRESS SYNDROME 857 0.0484
210 SEPTIC SHOCK 2104 0.0483
211 CONTRAINDICATED PRODUCT ADMINISTERED 1455 0.0480
212 IMPAIRED HEALING 1575 0.0479
213 IMMUNE THROMBOCYTOPENIA 219 0.0478
214 EXOSTOSIS 434 0.0475
215 BACTERAEMIA 563 0.0474
216 GANGRENE 284 0.0471
217 LYMPHOPENIA 661 0.0467
218 NEPHROTIC SYNDROME 320 0.0466
219 BLOOD PRESSURE SYSTOLIC DECREASED 212 0.0466
220 PULMONARY FIBROSIS 888 0.0462
221 SPONDYLITIS 167 0.0459
222 VENOUS THROMBOSIS 180 0.0458
223 ENTERITIS 293 0.0457
224 CREPITATIONS 136 0.0456
225 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 174 0.0455
226 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 294 0.0452
227 BLOOD CREATININE DECREASED 141 0.0450
228 LIVER FUNCTION TEST INCREASED 965 0.0449
229 NEUTROPHIL COUNT INCREASED 460 0.0449
230 ABDOMINAL ABSCESS 198 0.0448
231 HYPOALBUMINAEMIA 348 0.0447
232 CONGENITAL ANOMALY 346 0.0447
233 INTENTIONAL PRODUCT USE ISSUE 3913 0.0446
234 PNEUMONIA BACTERIAL 409 0.0445
235 AUTOIMMUNE DISORDER 434 0.0445
236 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 2431 0.0443
237 NORMAL NEWBORN 238 0.0437
238 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 218 0.0437
239 POOR VENOUS ACCESS 450 0.0434
240 DISSEMINATED INTRAVASCULAR COAGULATION 610 0.0433
241 RASH VESICULAR 209 0.0432
242 RHEUMATOID ARTHRITIS 4883 0.0430
243 JOINT DISLOCATION 449 0.0424
244 SENSORY LOSS 341 0.0423
245 LUPUS-LIKE SYNDROME 384 0.0423
246 JOINT EFFUSION 291 0.0422
247 THROMBOTIC THROMBOCYTOPENIC PURPURA 148 0.0420
248 PRESCRIBED OVERDOSE 811 0.0419
249 RENAL TUBULAR NECROSIS 407 0.0415
250 FEBRILE BONE MARROW APLASIA 176 0.0414
251 IMMUNOSUPPRESSION 365 0.0413
252 HEPATIC NECROSIS 155 0.0411
253 NEPHROPATHY TOXIC 461 0.0410
254 OSTEOARTHRITIS 1727 0.0407
255 ENCEPHALITIS 280 0.0404
256 APLASIA PURE RED CELL 139 0.0404
257 DRUG-INDUCED LIVER INJURY 1230 0.0392
258 ADRENAL INSUFFICIENCY 475 0.0391
259 FUNGAL SKIN INFECTION 158 0.0391
260 BACTERIAL INFECTION 729 0.0390
261 SHOCK HAEMORRHAGIC 318 0.0390
262 TASTE DISORDER 780 0.0384
263 RESPIRATORY FAILURE 2801 0.0384
264 SCIATICA 612 0.0384
265 PULMONARY TUBERCULOSIS 163 0.0381
266 FOOT DEFORMITY 421 0.0379
267 ORAL CANDIDIASIS 500 0.0379
268 ARTERIAL OCCLUSIVE DISEASE 298 0.0379
269 THROAT IRRITATION 1683 0.0375
270 PSORIATIC ARTHROPATHY 1511 0.0372
271 LARGE INTESTINE PERFORATION 258 0.0371
272 BREAST CANCER STAGE II 309 0.0371
273 HEPATIC ENZYME INCREASED 2517 0.0369
274 INFLAMMATORY MARKER INCREASED 182 0.0367
275 FIBRIN D DIMER INCREASED 130 0.0365
276 LOWER RESPIRATORY TRACT INFECTION 1645 0.0361
277 DIFFUSE LARGE B-CELL LYMPHOMA 275 0.0357
278 LOW BIRTH WEIGHT BABY 283 0.0356
279 HEMIPLEGIA 296 0.0355
280 GAIT INABILITY 1188 0.0355
281 LEUKOENCEPHALOPATHY 132 0.0354
282 SERUM FERRITIN INCREASED 186 0.0352
283 BLOOD THYROID STIMULATING HORMONE DECREASED 160 0.0352
284 PYELONEPHRITIS 305 0.0352
285 ACUTE RESPIRATORY FAILURE 673 0.0349
286 ARTHROPATHY 1940 0.0349
287 BLOOD CHOLESTEROL INCREASED 1609 0.0345
288 PULMONARY HAEMORRHAGE 269 0.0344
289 EPILEPSY 1051 0.0343
290 INFLAMMATION 1772 0.0343
291 MYOSITIS 307 0.0342
292 VENOOCCLUSIVE LIVER DISEASE 168 0.0340
293 RALES 197 0.0339
294 REBOUND EFFECT 383 0.0339
295 THERAPY PARTIAL RESPONDER 526 0.0337
296 ORGANISING PNEUMONIA 167 0.0337
297 THERAPY NON-RESPONDER 1510 0.0336
298 NIGHT SWEATS 1079 0.0335
299 HYPERTRANSAMINASAEMIA 232 0.0333
300 LUNG DISORDER 1630 0.0332
301 OSTEOPOROSIS 1367 0.0332
302 SINUS CONGESTION 446 0.0330
303 TOXIC EPIDERMAL NECROLYSIS 500 0.0329
304 HERPES VIRUS INFECTION 189 0.0328
305 OLIGURIA 203 0.0327
306 HAEMODYNAMIC INSTABILITY 249 0.0326
307 HEPATITIS 829 0.0324
308 THERAPEUTIC PRODUCT EFFECT DECREASED 1451 0.0324
309 FOETAL GROWTH RESTRICTION 196 0.0322
310 UPPER RESPIRATORY TRACT INFECTION 1477 0.0319
311 ARTHRITIS BACTERIAL 129 0.0314
312 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 186 0.0314
313 HYDRONEPHROSIS 235 0.0314
314 LEUKOPENIA 1556 0.0311
315 BODY TEMPERATURE INCREASED 631 0.0309
316 INTESTINAL ISCHAEMIA 170 0.0308
317 SKIN NECROSIS 159 0.0306
318 SYNOVIAL CYST 141 0.0305
319 PROTEINURIA 577 0.0303
320 CYTOKINE RELEASE SYNDROME 608 0.0303
321 JOINT SWELLING 3652 0.0302
322 BLOOD ALBUMIN DECREASED 240 0.0302
323 TREATMENT FAILURE 2502 0.0302
324 HEPATITIS B 179 0.0297
325 DRUG RESISTANCE 762 0.0296
326 APHTHOUS ULCER 230 0.0296
327 PARTIAL SEIZURES 155 0.0296
328 MUSCLE SPASTICITY 361 0.0294
329 STATUS EPILEPTICUS 329 0.0291
330 HYPOVOLAEMIC SHOCK 139 0.0290
331 HEMIPARESIS 487 0.0287
332 HAEMOLYTIC ANAEMIA 257 0.0287
333 END STAGE RENAL DISEASE 523 0.0286
334 ENDOCARDITIS 147 0.0286
335 BLOOD PRESSURE INCREASED 4340 0.0284
336 WHEEZING 1683 0.0284
337 INTERSTITIAL LUNG DISEASE 1373 0.0283
338 JOINT STIFFNESS 741 0.0282
339 COORDINATION ABNORMAL 393 0.0281
340 TUMOUR LYSIS SYNDROME 247 0.0280
341 BRONCHIECTASIS 189 0.0280
342 TACHYPNOEA 380 0.0279
343 CYTOPENIA 340 0.0277
344 HYPERTRIGLYCERIDAEMIA 162 0.0276
345 MOTOR DYSFUNCTION 282 0.0276
346 PRESCRIBED UNDERDOSE 551 0.0276
347 PANCYTOPENIA 1540 0.0275
348 DRUG LEVEL BELOW THERAPEUTIC 152 0.0275
349 ORAL HERPES 536 0.0274
350 POST-TRAUMATIC STRESS DISORDER 184 0.0274
351 HAEMATOCRIT DECREASED 543 0.0274
352 LEUKOCYTOSIS 490 0.0270
353 LUNG INFILTRATION 239 0.0270
354 BLISTER 1519 0.0270
355 EXPOSURE DURING PREGNANCY 1679 0.0270
356 ULCER 429 0.0269
357 MATERNAL EXPOSURE DURING PREGNANCY 2402 0.0269
358 HYPERAMMONAEMIA 134 0.0268
359 HYPERGLYCAEMIA 976 0.0268
360 PATHOGEN RESISTANCE 244 0.0267
361 MULTI-ORGAN FAILURE 462 0.0267
362 INFUSION SITE EXTRAVASATION 166 0.0266
363 DYSLIPIDAEMIA 135 0.0266
364 POLYARTHRITIS 140 0.0265
365 TUBULOINTERSTITIAL NEPHRITIS 497 0.0265
366 SEPSIS 2952 0.0264
367 AUTOIMMUNE HEPATITIS 184 0.0264
368 ATELECTASIS 253 0.0262
369 HYPERTENSION 5532 0.0261
370 OFF LABEL USE 22845 0.0261
371 HYPERBILIRUBINAEMIA 269 0.0259
372 PNEUMOTHORAX 411 0.0259
373 BLOOD URINE PRESENT 492 0.0259
374 NEPHROPATHY 241 0.0258
375 BLOOD URIC ACID INCREASED 148 0.0256
376 INTERVERTEBRAL DISC DEGENERATION 237 0.0256
377 NECROSIS 142 0.0255
378 THROMBOCYTOPENIA 2849 0.0255
379 BLOOD UREA INCREASED 426 0.0254
380 ENCEPHALOPATHY 621 0.0253
381 STAPHYLOCOCCAL INFECTION 833 0.0252
382 ADVERSE REACTION 334 0.0252
383 CYSTITIS 802 0.0252
384 ATRIOVENTRICULAR BLOCK COMPLETE 168 0.0251
385 MUSCULOSKELETAL STIFFNESS 2196 0.0250
386 OSTEOPENIA 380 0.0250
387 OPTIC NEURITIS 227 0.0250
388 STOMATITIS 1513 0.0249
389 AFFECT LABILITY 240 0.0249
390 FUNGAL INFECTION 830 0.0249
391 ILL-DEFINED DISORDER 1507 0.0248
392 HIP ARTHROPLASTY 378 0.0247
393 INTESTINAL PERFORATION 277 0.0247
394 SKIN LACERATION 268 0.0246
395 DELIRIUM 853 0.0246
396 RHINITIS 198 0.0245
397 HERPES ZOSTER 1410 0.0245
398 VITAMIN D DEFICIENCY 238 0.0244
399 MOUTH ULCERATION 513 0.0243
400 ANURIA 209 0.0243
401 DRUG INTOLERANCE 2345 0.0243
402 LOWER LIMB FRACTURE 464 0.0241
403 MYASTHENIA GRAVIS 195 0.0241
404 MUSCULOSKELETAL PAIN 1260 0.0240
405 HYPOXIA 846 0.0240
406 BRAIN OEDEMA 302 0.0239
407 PNEUMONITIS 650 0.0238
408 PREMATURE DELIVERY 380 0.0238
409 BLOOD LACTATE DEHYDROGENASE INCREASED 378 0.0238
410 ACUTE PULMONARY OEDEMA 133 0.0237
411 SPINAL OSTEOARTHRITIS 208 0.0237
412 EAR INFECTION 630 0.0237
413 HEPATIC CIRRHOSIS 437 0.0232
414 PRODUCT USE IN UNAPPROVED INDICATION 5755 0.0232
415 MOBILITY DECREASED 1667 0.0232
416 FEBRILE NEUTROPENIA 1539 0.0232
417 CHOLECYSTITIS ACUTE 131 0.0231
418 EAR PAIN 449 0.0231
419 WHITE BLOOD CELL COUNT INCREASED 886 0.0231
420 SKIN INFECTION 259 0.0231
421 VIRAL INFECTION 759 0.0228
422 CLOSTRIDIUM DIFFICILE INFECTION 497 0.0227
423 SINUSITIS 2332 0.0227
424 HEPATITIS CHOLESTATIC 137 0.0227
425 NECK PAIN 1269 0.0227
426 ENTEROCOLITIS 131 0.0227
427 POSTOPERATIVE WOUND INFECTION 153 0.0226
428 HEART RATE INCREASED 2242 0.0226
429 INFECTION 3272 0.0226
430 MUCOSAL INFLAMMATION 589 0.0225
431 GENERAL PHYSICAL HEALTH DETERIORATION 2592 0.0224
432 SPINAL COMPRESSION FRACTURE 185 0.0224
433 MUSCULAR WEAKNESS 2542 0.0223
434 RASH MACULO-PAPULAR 497 0.0223
435 RESPIRATORY DISTRESS 615 0.0223
436 PHARYNGITIS 275 0.0221
437 MYOCARDITIS 254 0.0221
438 COLITIS 839 0.0221
439 BLOOD CREATININE INCREASED 1445 0.0221
440 NASOPHARYNGITIS 4068 0.0220
441 MENINGITIS 147 0.0220
442 UROSEPSIS 203 0.0220
443 RESPIRATORY DISORDER 658 0.0220
444 SWELLING 2056 0.0219
445 EOSINOPHIL COUNT INCREASED 182 0.0218
446 HEPATOCELLULAR INJURY 309 0.0218
447 PNEUMONIA 7054 0.0218
448 BRONCHITIS 1610 0.0217
449 RESPIRATORY TRACT INFECTION 562 0.0216
450 LUNG INFECTION 335 0.0215
451 GASTROENTERITIS 314 0.0215
452 BONE MARROW FAILURE 437 0.0215
453 ACUTE KIDNEY INJURY 3288 0.0215
454 TEMPERATURE INTOLERANCE 221 0.0214
455 OEDEMA 1160 0.0214
456 PULMONARY MASS 318 0.0213
457 TRANSAMINASES INCREASED 474 0.0213
458 OSTEONECROSIS 694 0.0211
459 TOOTH ABSCESS 215 0.0211
460 DISEASE RECURRENCE 1000 0.0210
461 HEPATIC CYTOLYSIS 268 0.0210
462 INJURY 1477 0.0210
463 PYREXIA 7258 0.0210
464 HYPOPHOSPHATAEMIA 154 0.0208
465 CHRONIC KIDNEY DISEASE 1583 0.0208
466 COAGULOPATHY 347 0.0208
467 RENAL IMPAIRMENT 1736 0.0206
468 PULMONARY TOXICITY 146 0.0206
469 CHOLESTASIS 396 0.0206
470 SINUS BRADYCARDIA 199 0.0206
471 CARDIAC FAILURE ACUTE 137 0.0205
472 CONDITION AGGRAVATED 6254 0.0205
473 HEPATOMEGALY 202 0.0205
474 GAMMA-GLUTAMYLTRANSFERASE INCREASED 451 0.0203
475 GASTROOESOPHAGEAL REFLUX DISEASE 1638 0.0203
476 ORAL DISORDER 149 0.0203
477 PARAESTHESIA ORAL 293 0.0203
478 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1444 0.0203
479 SINUS DISORDER 402 0.0203
480 ARTHRITIS 1593 0.0202
481 GENERAL SYMPTOM 151 0.0201
482 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 590 0.0201
483 DEVICE RELATED INFECTION 308 0.0200
484 CATARACT 1185 0.0199
485 ABSCESS 317 0.0198
486 SPINAL DISORDER 188 0.0198
487 RASH ERYTHEMATOUS 945 0.0197
488 HYPOKALAEMIA 912 0.0197
489 HEPATOTOXICITY 439 0.0197
490 GENERALISED OEDEMA 243 0.0196
491 GASTROINTESTINAL DISORDER 1758 0.0196
492 DENTAL CARIES 217 0.0196
493 NODULE 256 0.0196
494 ACUTE HEPATIC FAILURE 268 0.0196
495 ALANINE AMINOTRANSFERASE INCREASED 1202 0.0196
496 TENDERNESS 204 0.0196
497 NEURALGIA 474 0.0195
498 RESPIRATORY TRACT CONGESTION 309 0.0194
499 DISCOMFORT 1186 0.0194
500 DRY MOUTH 1577 0.0194
501 HAEMOLYSIS 150 0.0194
502 SKIN ULCER 501 0.0194
503 ULCER HAEMORRHAGE 131 0.0193
504 RENAL CYST 153 0.0192
505 PURPURA 169 0.0191
506 TACHYCARDIA 1694 0.0190
507 OESOPHAGITIS 208 0.0190
508 NERVE COMPRESSION 175 0.0189
509 RED BLOOD CELL COUNT DECREASED 541 0.0189
510 ATAXIA 224 0.0189
511 PRODUCTIVE COUGH 901 0.0189
512 HYPERLIPIDAEMIA 225 0.0188
513 HEART RATE IRREGULAR 424 0.0187
514 SLEEP DISORDER 1322 0.0187
515 TENDON RUPTURE 231 0.0187
516 HEPATIC FAILURE 562 0.0186
517 DUODENAL ULCER 131 0.0185
518 ELECTROLYTE IMBALANCE 215 0.0185
519 VAGINAL DISCHARGE 187 0.0185
520 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 475 0.0184
521 UPPER-AIRWAY COUGH SYNDROME 152 0.0184
522 DYSPEPSIA 1810 0.0184
523 DRUG LEVEL DECREASED 187 0.0184
524 WEIGHT INCREASED 4114 0.0184
525 SPLENOMEGALY 214 0.0183
526 PLATELET COUNT INCREASED 238 0.0182
527 HEPATIC FUNCTION ABNORMAL 681 0.0182
528 HYPOAESTHESIA 2719 0.0181
529 SNEEZING 407 0.0181
530 MALNUTRITION 203 0.0181
531 SINUS TACHYCARDIA 257 0.0181
532 GLOMERULAR FILTRATION RATE DECREASED 221 0.0180
533 SHOCK 413 0.0179
534 BLOOD BILIRUBIN INCREASED 485 0.0179
535 DISABILITY 355 0.0179
536 AGRANULOCYTOSIS 333 0.0179
537 PERITONITIS 371 0.0179
538 CHEST DISCOMFORT 1834 0.0179
539 ROTATOR CUFF SYNDROME 229 0.0178
540 PLEURAL EFFUSION 1075 0.0176
541 IRON DEFICIENCY ANAEMIA 163 0.0176
542 PREMATURE BABY 531 0.0176
543 LIGAMENT SPRAIN 174 0.0176
544 DRUG LEVEL INCREASED 290 0.0175
545 INFUSION SITE PAIN 225 0.0174
546 ASCITES 513 0.0174
547 BLOOD ALKALINE PHOSPHATASE INCREASED 431 0.0173
548 WEIGHT FLUCTUATION 181 0.0173
549 URINE OUTPUT DECREASED 151 0.0173
550 COVID-19 3010 0.0171
551 PERIPHERAL SWELLING 2626 0.0170
552 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 175 0.0170
553 URTICARIA 2850 0.0170
554 CELLULITIS 857 0.0170
555 OSTEOMYELITIS 307 0.0169
556 ASTHMA 1913 0.0169
557 SUPRAVENTRICULAR TACHYCARDIA 162 0.0169
558 LOCALISED INFECTION 408 0.0169
559 FLUID RETENTION 858 0.0169
560 OROPHARYNGEAL PAIN 1558 0.0168
561 HYPOTENSION 3376 0.0168
562 HYPOMAGNESAEMIA 234 0.0168
563 SKIN HAEMORRHAGE 249 0.0168
564 ASPARTATE AMINOTRANSFERASE INCREASED 892 0.0168
565 TOOTH DISORDER 373 0.0168
566 BACK DISORDER 272 0.0167
567 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 284 0.0167
568 DISEASE PROGRESSION 1978 0.0167
569 NEUROTOXICITY 292 0.0166
570 SARS-COV-2 TEST POSITIVE 220 0.0166
571 FREQUENT BOWEL MOVEMENTS 450 0.0166
572 OROPHARYNGEAL DISCOMFORT 150 0.0166
573 KNEE ARTHROPLASTY 349 0.0166
574 HAEMODIALYSIS 139 0.0165
575 ANGINA PECTORIS 474 0.0165
576 FLANK PAIN 155 0.0165
577 NEUTROPENIA 2245 0.0165
578 NASAL CONGESTION 969 0.0165
579 PETECHIAE 172 0.0165
580 EAR DISCOMFORT 169 0.0164
581 PHARYNGEAL SWELLING 161 0.0164
582 HYPERCALCAEMIA 203 0.0164
583 RENAL FAILURE 2182 0.0164
584 ECONOMIC PROBLEM 249 0.0164
585 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 281 0.0164
586 PANCREATITIS ACUTE 366 0.0163
587 MIGRAINE 1554 0.0163
588 HYPERSENSITIVITY 3013 0.0162
589 APHASIA 490 0.0162
590 SLEEP APNOEA SYNDROME 309 0.0162
591 URINARY TRACT INFECTION 2760 0.0162
592 HAEMOGLOBIN DECREASED 1657 0.0161
593 COLITIS ULCERATIVE 721 0.0161
594 THROAT TIGHTNESS 436 0.0161
595 ARTHRALGIA 6691 0.0161
596 BASAL CELL CARCINOMA 251 0.0161
597 HAEMATURIA 550 0.0160
598 RHINORRHOEA 1035 0.0160
599 PERICARDIAL EFFUSION 370 0.0160
600 DIARRHOEA HAEMORRHAGIC 149 0.0159
601 HAEMOPTYSIS 442 0.0158
602 UPPER GASTROINTESTINAL HAEMORRHAGE 266 0.0158
603 COUGH 4409 0.0157
604 IMPAIRED QUALITY OF LIFE 226 0.0157
605 PARALYSIS 225 0.0157
606 MYELODYSPLASTIC SYNDROME 227 0.0157
607 ANAEMIA 2986 0.0156
608 ARTERIOSCLEROSIS 147 0.0156
609 CENTRAL NERVOUS SYSTEM LESION 214 0.0156
610 BRADYCARDIA 825 0.0155
611 DRY THROAT 158 0.0155
612 CARDIOGENIC SHOCK 223 0.0155
613 ILEUS 193 0.0155
614 SQUAMOUS CELL CARCINOMA 146 0.0155
615 FEELING HOT 947 0.0154
616 METABOLIC ACIDOSIS 493 0.0154
617 EYE INFLAMMATION 147 0.0154
618 DIABETES MELLITUS 1174 0.0154
619 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 739 0.0154
620 ANAPHYLACTIC REACTION 850 0.0154
621 LIVER DISORDER 681 0.0153
622 INFLUENZA 1710 0.0153
623 TOOTH FRACTURE 169 0.0153
624 SKIN LESION 420 0.0153
625 CONJUNCTIVITIS 284 0.0153
626 MITRAL VALVE INCOMPETENCE 172 0.0152
627 CARDIOMYOPATHY 224 0.0151
628 LYMPHADENOPATHY 535 0.0151
629 GENERALISED TONIC-CLONIC SEIZURE 250 0.0151
630 FOOT FRACTURE 286 0.0151
631 CEREBRAL INFARCTION 368 0.0150
632 PULMONARY OEDEMA 674 0.0150
633 GOUT 270 0.0150
634 POLYNEUROPATHY 180 0.0150
635 EOSINOPHILIA 262 0.0149
636 NEUTROPHIL COUNT DECREASED 608 0.0149
637 ALTERED STATE OF CONSCIOUSNESS 323 0.0149
638 CARDIOMEGALY 183 0.0149
639 CONFUSIONAL STATE 2404 0.0149
640 SUBARACHNOID HAEMORRHAGE 151 0.0148
641 DIVERTICULITIS 410 0.0148
642 HYPOCALCAEMIA 280 0.0148
643 GASTRITIS 388 0.0147
644 SEASONAL ALLERGY 208 0.0147
645 POOR QUALITY SLEEP 316 0.0147
646 HYPERKALAEMIA 514 0.0146
647 TOOTH INFECTION 193 0.0146
648 PULMONARY CONGESTION 193 0.0146
649 DYSARTHRIA 549 0.0146
650 BLOOD THYROID STIMULATING HORMONE INCREASED 134 0.0145
651 INTERVERTEBRAL DISC PROTRUSION 318 0.0145
652 ABDOMINAL DISCOMFORT 2439 0.0145
653 STEVENS-JOHNSON SYNDROME 323 0.0145
654 BRONCHOSPASM 207 0.0145
655 GASTROINTESTINAL INFECTION 130 0.0145
656 DYSPHAGIA 1373 0.0145
657 FACIAL PAIN 129 0.0144
658 ROAD TRAFFIC ACCIDENT 603 0.0144
659 HAEMATOCHEZIA 794 0.0144
660 EMPHYSEMA 145 0.0144
661 ANAPHYLACTIC SHOCK 370 0.0143
662 EATING DISORDER 305 0.0143
663 WEIGHT DECREASED 3997 0.0143
664 GASTRIC ULCER 270 0.0142
665 RECTAL HAEMORRHAGE 606 0.0141
666 CYST 175 0.0141
667 ERYTHEMA 2892 0.0141
668 SPUTUM DISCOLOURED 133 0.0140
669 RIB FRACTURE 288 0.0140
670 MELAENA 308 0.0140
671 FACE OEDEMA 236 0.0140
672 EYE INFECTION 158 0.0140
673 TOOTHACHE 253 0.0140
674 INJECTION SITE EXTRAVASATION 172 0.0139
675 CYANOSIS 219 0.0139
676 CONTUSION 1337 0.0139
677 ABDOMINAL PAIN 3225 0.0138
678 HAEMATOMA 358 0.0138
679 HEPATIC STEATOSIS 257 0.0138
680 BONE DISORDER 251 0.0138
681 PARAESTHESIA 2167 0.0138
682 CHOLECYSTITIS 164 0.0138
683 HIATUS HERNIA 178 0.0137
684 DYSPNOEA EXERTIONAL 515 0.0137
685 DIPLOPIA 355 0.0137
686 THERAPEUTIC RESPONSE DECREASED 828 0.0136
687 MACULAR DEGENERATION 163 0.0136
688 DEEP VEIN THROMBOSIS 879 0.0135
689 PULMONARY EMBOLISM 1280 0.0135
690 PLATELET COUNT DECREASED 1423 0.0133
691 HYPERTHYROIDISM 193 0.0133
692 PNEUMONIA ASPIRATION 330 0.0132
693 VENTRICULAR TACHYCARDIA 218 0.0132
694 HEPATITIS C 159 0.0132
695 RASH 5722 0.0131
696 DRUG INTERACTION 2080 0.0131
697 OEDEMA PERIPHERAL 1598 0.0131
698 ANHEDONIA 343 0.0130
699 MUSCULOSKELETAL CHEST PAIN 202 0.0130
700 WHITE BLOOD CELL COUNT DECREASED 1409 0.0130
701 CHILLS 1521 0.0130
702 JAUNDICE 349 0.0130
703 ACUTE MYELOID LEUKAEMIA 201 0.0129
704 HYPONATRAEMIA 725 0.0129
705 MASS 179 0.0128
706 TENDONITIS 198 0.0128
707 CIRCULATORY COLLAPSE 217 0.0127
708 LIMB INJURY 346 0.0127
709 PAIN IN EXTREMITY 3746 0.0127
710 CARPAL TUNNEL SYNDROME 177 0.0126
711 DRUG INEFFECTIVE 16640 0.0126
712 PERIPHERAL COLDNESS 173 0.0126
713 KIDNEY INFECTION 247 0.0126
714 LIVER FUNCTION TEST ABNORMAL 364 0.0125
715 PAIN 7665 0.0125
716 FEELING COLD 346 0.0124
717 GASTROINTESTINAL HAEMORRHAGE 1038 0.0124
718 PRODUCT USE ISSUE 2333 0.0124
719 BLOOD TEST ABNORMAL 174 0.0124
720 PSYCHOTIC DISORDER 365 0.0123
721 ABDOMINAL DISTENSION 1289 0.0123
722 APHONIA 172 0.0123
723 GASTROENTERITIS VIRAL 222 0.0123
724 UVEITIS 166 0.0122
725 BLOOD PRESSURE ABNORMAL 243 0.0122
726 BLOOD IRON DECREASED 145 0.0122
727 IMPAIRED GASTRIC EMPTYING 166 0.0122
728 RESTLESS LEGS SYNDROME 221 0.0121
729 COGNITIVE DISORDER 565 0.0121
730 BACK PAIN 2802 0.0120
731 FLUSHING 1225 0.0120
732 SMALL INTESTINAL OBSTRUCTION 148 0.0120
733 HEADACHE 7508 0.0120
734 ABDOMINAL PAIN UPPER 2459 0.0119
735 CHEST PAIN 2210 0.0119
736 ASTHENIA 4485 0.0119
737 DIABETES MELLITUS INADEQUATE CONTROL 211 0.0119
738 MYELOSUPPRESSION 429 0.0119
739 AMNESIA 774 0.0119
740 ANGIOEDEMA 526 0.0119
741 HYPERHIDROSIS 1526 0.0118
742 DYSPNOEA 6704 0.0118
743 IMMUNE SYSTEM DISORDER 156 0.0118
744 HYPOTHYROIDISM 378 0.0118
745 MEMORY IMPAIRMENT 1622 0.0118
746 FOETAL EXPOSURE DURING PREGNANCY 959 0.0118
747 HYPERTENSIVE CRISIS 131 0.0118
748 MUSCULOSKELETAL DISCOMFORT 202 0.0117
749 MUSCLE ATROPHY 148 0.0117
750 DEPRESSION 2646 0.0116
751 PALPITATIONS 1360 0.0116
752 SPINAL FRACTURE 231 0.0115
753 DRUG ERUPTION 203 0.0114
754 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 597 0.0114
755 CARDIAC ARREST 937 0.0113
756 PULMONARY HYPERTENSION 236 0.0113
757 GINGIVAL BLEEDING 154 0.0113
758 EJECTION FRACTION DECREASED 174 0.0112
759 RENAL INJURY 332 0.0112
760 NERVOUS SYSTEM DISORDER 347 0.0111
761 URINARY INCONTINENCE 329 0.0111
762 PALLOR 302 0.0111
763 MUSCLE SPASMS 2029 0.0110
764 PHOTOPHOBIA 207 0.0110
765 SKIN REACTION 155 0.0110
766 HAEMORRHOIDS 214 0.0110
767 ATRIAL FIBRILLATION 1067 0.0109
768 DYSURIA 403 0.0109
769 BLOOD POTASSIUM DECREASED 329 0.0109
770 ALOPECIA 2131 0.0108
771 NEUROPATHY PERIPHERAL 1032 0.0108
772 ACUTE MYOCARDIAL INFARCTION 319 0.0108
773 DECREASED APPETITE 2506 0.0108
774 MULTIPLE SCLEROSIS RELAPSE 738 0.0108
775 MENTAL STATUS CHANGES 299 0.0108
776 CARDIAC FAILURE 864 0.0108
777 BLOOD CREATINE PHOSPHOKINASE INCREASED 307 0.0107
778 FATIGUE 8236 0.0106
779 BLOOD PRESSURE DECREASED 702 0.0106
780 VOMITING 4964 0.0105
781 HYPOAESTHESIA ORAL 159 0.0105
782 GLAUCOMA 203 0.0105
783 MULTIPLE SCLEROSIS 500 0.0104
784 JOINT INJURY 223 0.0104
785 LACTIC ACIDOSIS 338 0.0104
786 GALLBLADDER DISORDER 186 0.0104
787 VERTIGO 628 0.0103
788 PHOTOSENSITIVITY REACTION 170 0.0103
789 RENAL FAILURE ACUTE 435 0.0102
790 MUSCLE TIGHTNESS 166 0.0102
791 RASH PRURITIC 555 0.0102
792 LYMPHOMA 158 0.0102
793 DRY EYE 510 0.0102
794 ANXIETY 2905 0.0102
795 DIARRHOEA 6572 0.0102
796 GAIT DISTURBANCE 1944 0.0101
797 MALAISE 4428 0.0101
798 MUSCULOSKELETAL DISORDER 191 0.0100
799 SCAR 170 0.0099
800 INSOMNIA 2616 0.0098
801 CHOLELITHIASIS 322 0.0098
802 BLINDNESS 399 0.0098
803 PRURITUS 3762 0.0098
804 ANKLE FRACTURE 151 0.0097
805 MALIGNANT MELANOMA 130 0.0097
806 NAUSEA 7672 0.0097
807 THERAPEUTIC RESPONSE SHORTENED 320 0.0096
808 BALANCE DISORDER 827 0.0096
809 LIMB DISCOMFORT 294 0.0095
810 NEPHROLITHIASIS 434 0.0095
811 DYSPHONIA 553 0.0094
812 VISUAL IMPAIRMENT 1170 0.0094
813 UPPER LIMB FRACTURE 188 0.0094
814 COLD SWEAT 166 0.0094
815 PRESYNCOPE 228 0.0094
816 INJECTION SITE REACTION 644 0.0093
817 PSYCHOMOTOR HYPERACTIVITY 155 0.0093
818 ARRHYTHMIA 441 0.0093
819 FALL 3096 0.0093
820 CARDIO-RESPIRATORY ARREST 388 0.0093
821 URINARY RETENTION 307 0.0092
822 PRODUCT PRESCRIBING ISSUE 200 0.0092
823 HOT FLUSH 688 0.0091
824 CEREBRAL HAEMORRHAGE 326 0.0091
825 ISCHAEMIC STROKE 161 0.0090
826 THYROID DISORDER 139 0.0090
827 SWELLING FACE 587 0.0090
828 BONE DENSITY DECREASED 282 0.0090
829 BLOOD TRIGLYCERIDES INCREASED 159 0.0090
830 HERNIA 174 0.0090
831 EPISTAXIS 672 0.0090
832 PSORIASIS 1172 0.0090
833 INFLUENZA LIKE ILLNESS 738 0.0090
834 MANIA 146 0.0089
835 PAIN IN JAW 251 0.0089
836 SKIN DISORDER 293 0.0088
837 UNDERDOSE 641 0.0088
838 SENSORY DISTURBANCE 140 0.0087
839 CONSTIPATION 1877 0.0086
840 DIZZINESS 4282 0.0086
841 HALLUCINATION, VISUAL 181 0.0086
842 POLLAKIURIA 356 0.0085
843 ELECTROCARDIOGRAM QT PROLONGED 306 0.0085
844 GASTRIC DISORDER 290 0.0084
845 PROCEDURAL PAIN 232 0.0084
846 EYE PAIN 471 0.0083
847 EYE DISORDER 274 0.0083
848 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1501 0.0083
849 SOMNOLENCE 1667 0.0083
850 ABDOMINAL PAIN LOWER 209 0.0083
851 HAEMATEMESIS 206 0.0081
852 DIABETIC KETOACIDOSIS 195 0.0081
853 RENAL DISORDER 378 0.0081
854 POST PROCEDURAL COMPLICATION 155 0.0081
855 DERMATITIS 169 0.0081
856 ILLNESS 826 0.0080
857 COMA 381 0.0080
858 PANCREATITIS 419 0.0079
859 BLOOD SODIUM DECREASED 149 0.0079
860 FEMUR FRACTURE 244 0.0079
861 ORAL PAIN 176 0.0079
862 INTERNATIONAL NORMALISED RATIO INCREASED 223 0.0078
863 INCREASED APPETITE 149 0.0078
864 INTESTINAL OBSTRUCTION 291 0.0077
865 FEELING JITTERY 147 0.0077
866 RETCHING 164 0.0077
867 HEAD DISCOMFORT 136 0.0077
868 INTENTIONAL PRODUCT MISUSE 671 0.0077
869 TINNITUS 352 0.0077
870 MOVEMENT DISORDER 246 0.0077
871 LABORATORY TEST ABNORMAL 226 0.0077
872 SEIZURE 882 0.0076
873 DEPRESSED LEVEL OF CONSCIOUSNESS 299 0.0076
874 HIP FRACTURE 242 0.0075
875 AGITATION 551 0.0075
876 DEHYDRATION 997 0.0075
877 MYALGIA 1261 0.0074
878 DISORIENTATION 292 0.0074
879 TREMOR 1216 0.0073
880 NERVOUSNESS 382 0.0073
881 THROMBOSIS 588 0.0073
882 NEOPLASM PROGRESSION 252 0.0072
883 EYE SWELLING 268 0.0072
884 SYNCOPE 720 0.0072
885 INTENTIONAL DOSE OMISSION 205 0.0072
886 LACRIMATION INCREASED 217 0.0072
887 DISTURBANCE IN ATTENTION 385 0.0071
888 RHABDOMYOLYSIS 295 0.0071
889 SKIN DISCOLOURATION 325 0.0071
890 OSTEONECROSIS OF JAW 174 0.0070
891 CORONARY ARTERY DISEASE 212 0.0070
892 DEAFNESS 183 0.0070
893 SPEECH DISORDER 366 0.0070
894 RESTLESSNESS 252 0.0069
895 BONE PAIN 403 0.0069
896 MEDICATION ERROR 382 0.0069
897 VISION BLURRED 939 0.0068
898 RASH PAPULAR 153 0.0068
899 DYSSTASIA 199 0.0068
900 MENTAL DISORDER 296 0.0068
901 BURNING SENSATION 473 0.0067
902 INCORRECT PRODUCT ADMINISTRATION DURATION 146 0.0067
903 SKIN FISSURES 131 0.0067
904 LOSS OF CONSCIOUSNESS 853 0.0067
905 RASH MACULAR 232 0.0066
906 HEAD INJURY 208 0.0066
907 CHROMATURIA 148 0.0065
908 SKIN EXFOLIATION 550 0.0065
909 MUSCLE TWITCHING 150 0.0065
910 PREGNANCY 130 0.0065
911 LETHARGY 368 0.0064
912 TREATMENT NONCOMPLIANCE 348 0.0064
913 FAECES DISCOLOURED 137 0.0063
914 TOXICITY TO VARIOUS AGENTS 1062 0.0063
915 ADVERSE DRUG REACTION 560 0.0062
916 IMPAIRED WORK ABILITY 133 0.0062
917 SKIN CANCER 133 0.0062
918 DEPRESSED MOOD 326 0.0062
919 TRANSIENT ISCHAEMIC ATTACK 208 0.0062
920 ADVERSE EVENT 562 0.0061
921 BLOOD GLUCOSE INCREASED 1129 0.0060
922 VISUAL ACUITY REDUCED 197 0.0059
923 OCULAR HYPERAEMIA 280 0.0059
924 HAEMORRHAGE 614 0.0059
925 LIP SWELLING 195 0.0058
926 ECZEMA 304 0.0058
927 HYPOGLYCAEMIA 281 0.0058
928 HALLUCINATION 434 0.0058
929 DYSGEUSIA 426 0.0057
930 GLYCOSYLATED HAEMOGLOBIN INCREASED 144 0.0057
931 HYPERSOMNIA 160 0.0056
932 MALIGNANT NEOPLASM PROGRESSION 570 0.0056
933 EMOTIONAL DISORDER 171 0.0055
934 RASH GENERALISED 141 0.0054
935 PANIC ATTACK 197 0.0054
936 UNRESPONSIVE TO STIMULI 139 0.0054
937 PRODUCT QUALITY ISSUE 731 0.0054
938 EMOTIONAL DISTRESS 651 0.0054
939 OVERDOSE 1160 0.0054
940 HYPOPHAGIA 136 0.0053
941 CEREBROVASCULAR ACCIDENT 888 0.0052
942 CARDIAC DISORDER 487 0.0052
943 PRODUCT DOSE OMISSION IN ERROR 147 0.0052
944 FEELING ABNORMAL 1241 0.0052
945 RESPIRATORY ARREST 142 0.0051
946 CARDIAC FAILURE CONGESTIVE 404 0.0050
947 CONVULSION 284 0.0050
948 NEOPLASM MALIGNANT 331 0.0050
949 MOOD SWINGS 157 0.0049
950 SWOLLEN TONGUE 152 0.0049
951 PLASMA CELL MYELOMA 186 0.0048
952 EYE PRURITUS 160 0.0048
953 THERAPEUTIC RESPONSE UNEXPECTED 202 0.0045
954 UNEVALUABLE EVENT 333 0.0044
955 ABNORMAL BEHAVIOUR 173 0.0044
956 DYSKINESIA 175 0.0043
957 ACNE 324 0.0043
958 FLATULENCE 242 0.0043
959 HYPOACUSIS 180 0.0042
960 SURGERY 243 0.0041
961 EYE IRRITATION 235 0.0041
962 LUNG NEOPLASM MALIGNANT 167 0.0041
963 MYOCARDIAL INFARCTION 708 0.0041
964 NO ADVERSE EVENT 730 0.0040
965 ABORTION SPONTANEOUS 161 0.0040
966 AGGRESSION 199 0.0040
967 CRYING 143 0.0039
968 IRRITABILITY 231 0.0038
969 PRODUCT DOSE OMISSION ISSUE 1082 0.0037
970 DRUG EFFECT INCOMPLETE 131 0.0036
971 SUICIDAL IDEATION 330 0.0036
972 BLOOD GLUCOSE DECREASED 160 0.0033
973 DEATH 2862 0.0033
974 DRY SKIN 424 0.0032
975 DERMATITIS ATOPIC 162 0.0031
976 HOSPITALISATION 469 0.0030
977 SUICIDE ATTEMPT 174 0.0029
978 DRUG EFFECT DECREASED 145 0.0027
979 THERAPY INTERRUPTED 176 0.0025
980 INJECTION SITE PRURITUS 147 0.0022
981 INJECTION SITE SWELLING 165 0.0022
982 BREAST CANCER 200 0.0021
983 INCORRECT DOSE ADMINISTERED 487 0.0021
984 SKIN BURNING SENSATION 152 0.0021
985 DRUG DEPENDENCE 325 0.0020
986 INJECTION SITE ERYTHEMA 242 0.0019
987 DRUG ABUSE 154 0.0018
988 INJECTION SITE BRUISING 146 0.0018
989 INJECTION SITE PAIN 522 0.0017
990 DRUG WITHDRAWAL SYNDROME 145 0.0017
991 DRUG DOSE OMISSION 176 0.0011
992 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 196 0.0010